How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
NeuroPace enters this update cycle with its price target unchanged, reflecting a steady view from covering analysts. Instead of reacting to new commentary, you are looking at a story where the official target remains in place while the underlying thesis may still be evolving. Read on to see how to track those shifts and build your own view as fresh information comes through. Stay updated as the Fair Value for NeuroPace shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on NeuroPace. Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives! NasdaqGM:NPCE 1-Year Stock Price Chart See how NeuroPace's fair value stacks up across multiple valuation models — not just analyst targets. How This Changes the Fair Value For NeuroPace Fair value estimate: no change reported Revenue growth assumptions: no ch
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace Announces FDA Approval of ECoG Assistantâ„¢, Advancing AI-Driven Epilepsy Care [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) MeetingBusiness Wire
- NeuroPace Announces FDA Approval of ECoG Assistantâ„¢, Advancing AI-Driven Epilepsy CareBusiness Wire
- Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift? [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 5/12/26 - Miss
NPCE
Analyst Actions
- 3/19/26 - Wells Fargo & Company
NPCE
Sec Filings
- 6/8/26 - Form 8-K
- 6/5/26 - Form 4
- 6/5/26 - Form 4
- NPCE's page on the SEC website